Conmed (CNMD) Net Margin Growth (3y) (2013 - 2026)
Conmed (CNMD) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 300.00 |
| 10 | Conmed | 1.55 Bn | 1.51 Bn | 197.46 Mn | 239.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 239.00 |
| Mar 31, 2026 | 375.00 |
| Dec 31, 2025 | -611.00 |
| Sep 30, 2025 | -1,593.00 |
| Jun 30, 2025 | 6,697.00 |
| Mar 31, 2025 | -430.00 |
| Dec 31, 2024 | 84.00 |
| Sep 30, 2024 | 946.00 |
| Jun 30, 2024 | 382.00 |
| Mar 31, 2024 | 207.00 |
| Dec 31, 2023 | 437.00 |
| Sep 30, 2023 | 232.00 |
| Jun 30, 2023 | 2,169.00 |
| Mar 31, 2023 | -215.00 |
| Dec 31, 2022 | 496.00 |
| Sep 30, 2022 | 1,379.00 |
| Jun 30, 2022 | -6,310.00 |
| Mar 31, 2022 | 571.00 |
| Dec 31, 2021 | 247.00 |
| Sep 30, 2021 | 313.00 |